Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: A potential role in autocrine growth regulation

Endocrinology

Volumn 137, Issue 2, 1996, Pages 486-494

  Di Simone, Nicoletta ^a   Crowley Jr , William F ^a   Wang, Qi Fa ^a   Sluss, Patrick M ^a   Schneyer, Alan L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN 2 RECEPTOR; FOLLISTATIN; INHIBIN; MESSENGER RNA; RECEPTOR SUBUNIT; RECOMBINANT ACTIVIN; RECOMBINANT FOLLISTATIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; GROWTH REGULATION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL;

EID: 0030048782     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.2.8593793     Document Type: Article

References (45)

1. Ries LAG 1993 Ovarian cancer. Survival and treatment differences by age. Cancer [Suppl 2] 71:524-529
2. Pfeiderer A 1984 A diagnosis and staging of ovarian cancer. J Cancer Res Clin Oncol 197:81-88
3. Piver MS, Baker TR, Piedmante M, Sandecki AM 1991 Epidemiology and etiology of ovarian cancer. Semin Oncol 18:177-185
4. Hamilton TC 1992 Ovarian cancer. I. Biology. Curr Probl Cancer 16:1-57
5. Jindal SK, Snoey DM, Lobb DK, Dorrington JH 1994 Transforming growth factor alpha localization and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol Oncol 53:17-23
6. Hurteau J, Rodriguez GC, Whitaker RS, Shah S, Mills G, Bast R, Berchuck A 1994 Transforming growth factor beta inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer 74:93-99
7. Berchuck AR, Rodriquez G, Olt G, Whitaker R, Boente MP, Bradley AA, Clarke-Peterson DL, Bast RC 1992 Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor beta. Am J Obstet Gynecol 166:676-684
8. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin Sawchenko P, Spiess J, Rivier J 1988 Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 44:1-34
9. Mathews LS 1995 Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev 15:310-341
10. Woodruff TK, Lyon RJ, Hansen SE, Rice GC, Mather JP 1990 Inhibin and activin locally regulate rat ovarian folliculogenesis. Endocrinology 127:3196-3205
11. Woodruff TK, Krummen LA, Lyon RJ, Stocks DL, Mather JP 1993 Recombinant human inhibin A and recombinant human activin A regulate pituitary and ovarian function in the adult female rat. Endocrinology 132:2332-2341
12. Sugino K, Kurosawa N, Nakamura T, Takio K, Shimasaki S, Ling N, Titani K, Sugino H 1992 Molecular heterogeneity of follistatin, an activin-binding protein. J Biol Chem 68:15579-15587
13. Schneyer A, Rzucidlo DA, Sluss PM, Crowley Jr WF 1994 Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology 135:667-674
14. Xiao S, Farnsworth PG, Findlay JK 1992 Interaction between activin and follicle-stimulating hormone-suppressing protein/follistatin in the regulation of basal inhibin production by cultured rat granulosa cells. Endocrinology 131:2365-2370
15. Findlay JK 1993 An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 48: 15-23
16. Inouye S, Guo Y, Depaolo L, Shimonaka M, Ling N, Shimasaki S 1991 Recombinant expression of human follistatin with 315 and 288 amino acids: chemical and Biological comparison with native porcine follistatin. Endocrinology 129:815-822
17. Huang SS, O'Grady P, Huang JS 1988 Human transforming growth factor beta-alpha-2-macroglobulin complex is a latent form of transforming growth factor beta. J Biol Chem 263:1535-1541
18. Matzuk MM, Finegold MJ, Su JJ, Hsueh AJW, Bradley A 1992 Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313-319
19. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu L, Bradley A 1994 Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA 91:8817-8821
20. Bernstein JR, Crowley Jr WF, Schneyer AL 1990 An improved method of purifying inhibin radioligand for radioimmunoassay. Biol Reprod 43:492-496
21. Schneyer AL, Mason AJ, Burton LE, Ziegner JR, Crowley WF 1990 Immunoreactive inhibin alpha subunit in human serum: implications for RIA. J Clin Endocrinol Metab 70:1208-1212
22. Lambert-Messerlian GM, Isaacson K, Crowley WFJ, Sluss P, Schneyer AL 1994 Human follicular fluid contains pro- and C-terminal immunoreactive alpha-inhibin precursor proteins. J Clin Endocrinol Metab 78:433-439
23. Wang QF, Khoury RH, Smith PC, McConnell DS, Padmanahban V, Midgley Jr AR, Schneyer AL, Crowley Jr WF, Sluss PM, A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1). J Clin Endocrinol Metab, in press
24. Filicori M, Butler JP, Crowley Jr WF 1984 Neuroendocrine regulation of the corpus luteum in the human: evidence for pulsatile progesterone secretion. J Clin Invest 73:1638-1647
25. Rodbard D, Munson PJ, Delean A 1978 Improved curve-fitting, parallelism testing, and optimization for radioligand assays. In: Anonymous (ed) Radioimmunoassay and Related Procedures in Medicine. International Atomic Energy Agency, Vienna, vol 1:469
26. Nakamura T, Sugino S, Titani K, Sugino H 1991 Follistatin, an activin binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. J Biol Chem 266:19432-19437
27. Jindal SK, Ishii E, Letarte M, Vera S, Teerds S, Dorrington JH 1995 Regulation of TGF alpha gent? expression in a human ovarian surface epithelial cell line. Biol Reprod 52:1027-1037
28. Robertson DM, Tsonis CG, McLachlin RI, Handelsman DJ, Leask R, Baird DT, McNeilly AS, Hayward S, Healy DL, Findlay JK, Burger HG, DeKretser DM 1988 Comparison of inhibin immunological and in vitro biological activities in human serum. J Clin Endocrinol Metab 67:438-443
29. Fischer WH, Vaughan J, Husken-Hindi P, Park M, Vale WW, The intermolecular disulfide bond in activin is required for high affinity binding to follistatin. 77th Annual Meeting of The Endocrine Society, Washington DC, 1995, p 199 (Abstract P1-348)
30. Shoham Z 1994 Epidemiology, etiology and fertility drugs in ovarian epithelial carcinoma: where are we today? Fertil Steril 62:433-448
31. Biskind MS, Biskind GS 1994 Development of tumors in the rat ovary after transplantation into the spleen. Proc Soc Exp Biol Med 55:176-179
32. Cramer DW, Welch WR 1983 Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71:717-721
33. Walker LN, Bowen-Pope DF, Reidy MA 1984 Secretion of platelet-derived growth factor (PDGF)-like activity by arterial smooth muscle cells is induced as a response to injury. J Cell Biol 99:416a
34. Sporn MB, Roberts AB 1985 Autocrine growth factors and cancer. Nature 313:745-747
35. Robertson DM, Giacometti M, Folds LM, Lahnstein J, Goss NH, Heam MTW, DeKretser DM 1989 Isolation of inhibin α-subunit precursor proteins from bovine follicular fluid. Endocrinology 125: 2141-2149
36. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB 1985 Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 82:119-123
37. Fynan TM, Reiss M 1993 Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis. Crit Rev Oncogen 4:493-540
38. Lappohn RE, Burger HG, Bouma J, Bangah M, Krans M, deBruijn WA 1989 Inhibin as a marker for granulosa-cell tumors. N Engl J Med 321:790-793
39. Shikone T, Matzuk MM, Perlas E, Finegold MJ, Lewis KA, Vale W, Bradley A, Hsueh AJW 1994 Characterization of gonadal sex cord-stromal tumor cell lines from inhibin alpha and p53-deficient mice: the role of activin as an automne growth factor. Mol Endocrinol 8:983-995
40. Cooke I, O'Brien MO, Charnock FM, Groome N, Ganesan TS 1995 Inhibin as a marker for ovarian cancer. Br J Cancer 71:1046-1050
41. Blaakaer JB, J, Micic S, Morris ID, Hording U, Bennett P, Toftager-Larsen K, Djursing H, Block JE 1993 Immunoreactive inhibin-production in post-menopausal women with malignant epithelial ovarian tumors. Eur J Obstet Gynecol Reprod Biol 52:105-110
42. Mayo KE, Cerelli GM, Spiess J, Rivier J, Rosenfeld MG, Evans RM, Vale W 1986 Inhibin A-subunit cDNAs from porcine ovary and human placenta. Proc Natl Acad Sci USA 83:5849-5853
43. Mason AJ 1988 Structure and recombinant expression of human inhibin and activin. In: Hodgen GD, Rosenwaks Z, Spieler JM (eds) Non-Steroidal Gonadal Factors. Jones Institute Press, Norfolk, pp 15-21
44. Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A, Ueno N, Ying SY, Ling N, Guillemin R 1988 Primary structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci USA 85:4218-4222
45. Donaldson CJ, Mathews LM, Vale WW 1995 Molecular cloning and binding properties of the human type II activin receptor. Biochem Biophys Res Commun 184:310-316